Learning Objective #1: explain the advantages of decreasing the time to respond to heart attack symptoms | |||
Learning Objective #2: describe an innovative approach for heart attack response education |
Purpose: The prompt response to acute myocardial
infarction (AMI) symptoms could reduce mortality and morbidity through use of time-dependent
treatments. Long delays in seeking care exclude many from these options. Senior
citizens are at “high risk” for long delay. The aim of this research is to
explore a cost-effective means to reduce delay through rapid decision-making
and action.
Methods: A prospective, community intervention has
been used. The Leventhal Self-Regulatory Model
provides the framework. Community senior
center groups were randomly assigned as either a treatment or control group. Every group received the National Heart
Lung and Blood Institute's program, Act in Time to Heart Attack Signs. The treatment group also received individual
counseling and rehearsal of correct response to AMI symptoms. The control group
did not receive the counseling or rehearsal. A sample of 128 has been
obtained. Both groups completed a questionnaire on knowledge of
AMI symptoms and appropriate actions before the programs. The control group
completed a post-test after the program. The treatment group received the
intervention after the program and then completed the post-test. Information
about knowledge retention is being collected from both groups at six months via
a telephone survey.
Results: Data analysis is in progress. It is
hypothesized that the treatment group will have a significantly higher
knowledge level of AMI symptoms and the appropriate response after the intervention, and at the six month
follow-up. Descriptive statistics will be used to summarize the demographics,
test responses, and the telephone survey results. Two-sample T-tests will compare
the groups' retention of knowledge and intention to act.
Implications: This is a pilot study, testing the feasibility and efficacy of this intervention. Results can guide the development of larger scale studies with other high-risk populations.